KAIROS PHARMA LTD
KAPA·48301N104·US·Common Stock·Healthcare - Biotechnology-13D/G
KAPA (KAIROS PHARMA LTD) is held by 12 institutional investors as of Q2 2026. Largest holders: CITADEL ADVISORS LLC ($118,883), VANGUARD CAPITAL MANAGEMENT LLC ($89,041), Virtu Financial LLC ($31,000). Net institutional sentiment: Mixed.
12
Holders
$352,570
Total Value
64% (11)
Consensus
7 buying - 4 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 12, 2026 · Insiders Dec 30, 2025 · Activists Aug 14, 2025 · Congress none
InsiderBNBhowmick NeilVest 172K shOct 8, 2025
InsiderSRSinghvi RahulVest 19K shOct 8, 2025
InsiderKMKeyoung Hansoo MichaelVest 19K shOct 8, 2025
Checking access…
Top Holders
Checking access…
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer